These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21727251)

  • 21. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
    Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
    J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study of the association between the kynurenine-3-monooxygenase gene and depression].
    Lezheiko TV; Golimbet VE; Andryushchenko AV; Melik-Pashayan AE; Mironova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):92-95. PubMed ID: 28139632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia.
    Wonodi I; Hong LE; Stine OC; Mitchell BD; Elliott A; Roberts RC; Conley RR; McMahon RP; Thaker GK
    Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):282-9. PubMed ID: 18553389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: an association study.
    Holtze M; Saetre P; Erhardt S; Schwieler L; Werge T; Hansen T; Nielsen J; Djurovic S; Melle I; Andreassen OA; Hall H; Terenius L; Agartz I; Engberg G; Jönsson EG; Schalling M
    Schizophr Res; 2011 Apr; 127(1-3):270-2. PubMed ID: 21030213
    [No Abstract]   [Full Text] [Related]  

  • 25. Kynurenine 3-monooxygenase (KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survival in canine melanoma.
    Liu IL; Chung TF; Huang WH; Hsu CH; Liu CC; Chiu YH; Huang KC; Liao AT; Lin CS
    Vet Comp Oncol; 2021 Mar; 19(1):79-91. PubMed ID: 32720434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.
    Hughes TD; Güner OF; Iradukunda EC; Phillips RS; Bowen JP
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics.
    Maddison DC; Alfonso-Núñez M; Swaih AM; Breda C; Campesan S; Allcock N; Straatman-Iwanowska A; Kyriacou CP; Giorgini F
    PLoS Genet; 2020 Nov; 16(11):e1009129. PubMed ID: 33170836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum kynurenic acid is reduced in affective psychosis.
    Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
    Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease.
    Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I
    Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback.
    Wilson K; Auer M; Binnie M; Zheng X; Pham NT; Iredale JP; Webster SP; Mole DJ
    Cell Death Dis; 2016 Apr; 7(4):e2197. PubMed ID: 27077813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial expression of human kynurenine 3-monooxygenase: solubility, activity, purification.
    Wilson K; Mole DJ; Binnie M; Homer NZ; Zheng X; Yard BA; Iredale JP; Auer M; Webster SP
    Protein Expr Purif; 2014 Mar; 95(100):96-103. PubMed ID: 24316190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.
    Wonodi I; Schwarcz R
    Schizophr Bull; 2010 Mar; 36(2):211-8. PubMed ID: 20147364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel causative role of imbalanced kynurenine pathway in ulcerative colitis: Upregulation of KMO and KYNU promotes intestinal inflammation.
    Shi Y; Luo S; Zhai J; Chen Y
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166929. PubMed ID: 37918679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kynurenine 3-monooxygenase limits de novo NAD
    Zhai Y; Chavez JA; D'Aquino KE; Meng R; Nawrocki AR; Pocai A; Wang L; Ma LJ
    Am J Physiol Cell Physiol; 2024 May; 326(5):C1423-C1436. PubMed ID: 38497113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
    Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
    Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating Nrf2/ARE pathway in mouse model of depression: In-vivo and In-silico studies.
    Bansal Y; Singh R; Sodhi RK; Khare P; Dhingra R; Dhingra N; Bishnoi M; Kondepudi KK; Kuhad A
    Neuropharmacology; 2022 Sep; 215():109169. PubMed ID: 35753430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
    Carpenedo R; Meli E; Peruginelli F; Pellegrini-Giampietro DE; Moroni F
    J Neurochem; 2002 Sep; 82(6):1465-71. PubMed ID: 12354294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury.
    Zheng X; Zhang A; Binnie M; McGuire K; Webster SP; Hughes J; Howie SEM; Mole DJ
    Exp Mol Med; 2019 Feb; 51(2):1-14. PubMed ID: 30760699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased cortical kynurenate content in schizophrenia.
    Schwarcz R; Rassoulpour A; Wu HQ; Medoff D; Tamminga CA; Roberts RC
    Biol Psychiatry; 2001 Oct; 50(7):521-30. PubMed ID: 11600105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice.
    Kubo H; Hoshi M; Mouri A; Tashita C; Yamamoto Y; Nabeshima T; Saito K
    Immunol Lett; 2017 Jan; 181():94-100. PubMed ID: 27889626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.